Navigating MHRA Guidelines & Clinical Trial Regulations for CAR & TCR Therapies
- Clarify the latest MHRA regulations shaping CAR-T and TCR-T therapy development, including decentralized manufacturing and personalized treatment pathways to accelerate patient access to safe, specialized therapies
- Outline approaches to documentation, engagement, and compliance that support smooth regulatory interactions
- Evaluate the impact of MRHA legislation on CAR and TCR therapy trials